Pacific Biosciences Of California (PACB) Tax Provisions (2021 - 2026)

Pacific Biosciences Of California's Tax Provisions history runs 5 years deep, the most recent figure standing at $184000.0 for Q1 2026.

• On a quarterly basis, Tax Provisions rose 160.93% year-over-year to $184000.0 in Q1 2026; TTM through Mar 2026 was $804000.0, a 5642.86% increase from a year earlier, with the FY2025 full-year figure at $318000.0, up 0.63% from the prior year.
• Tax Provisions slipped to $184000.0 in Q1 2026 per PACB's latest filing, from $202000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $383000.0 in Q3 2025 and bottomed at -$10.7 million in Q3 2023.
• The 4-year median for Tax Provisions is $109500.0 (2025), against an average of -$1.3 million.
• Across the five-year window, Tax Provisions sank 36.08% in 2025 and surged 160.93% in 2026, its largest moves.
• Year by year, Tax Provisions stood at -$718000.0 in 2023, then jumped by 144.01% to $316000.0 in 2024, then plunged by 36.08% to $202000.0 in 2025, then retreated by 8.91% to $184000.0 in 2026.
• Per Business Quant, the three latest PACB Tax Provisions figures stand at $184000.0 (Q1 2026), $202000.0 (Q4 2025), and $383000.0 (Q3 2025).